2012 Fiscal Year Final Research Report
The genetic immunotherapy by novel nasal spray vaccine for melanomausing the next generation type virus vector
Project/Area Number |
23659549
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Dermatology
|
Research Institution | Mie University |
Principal Investigator |
KAWANO Mitsuo 三重大学, 大学院・医学系研究科, 講師 (00234097)
|
Co-Investigator(Kenkyū-buntansha) |
YAMANAKA Keiichi 三重大学, 医学系研究科, 准教授 (70314135)
|
Project Period (FY) |
2011 – 2012
|
Keywords | 皮膚腫瘍学 |
Research Abstract |
To establish a novel genetic immunotherapy instead of conventional chemotherapy and radiotherapy against refractory malignant melanoma, we have developed the parainfluenza type 2 virus vector introduced TRP-2 gene known as melanoma differentiation antigen or Ag85B gene inducing strong Th1 adjuvant activity. We analyzed the antitumor effect and the immune mechanisms by intranasal administrationto melanoma like model mice using the next generation spray vaccine for melanoma.
|
Research Products
(12 results)
-
-
-
[Journal Article] Legume lectins inhibit human parainfluenza virus type 2 infection by interfering with the entry2012
Author(s)
Uematsu J, Koyama A, Takano S, Ura Y, Tanemura M, Kihira S, Yamamoto H, Kawano M, Tsurudome M, O'Brien M, Komada H
-
Journal Title
Viruses
Volume: 4(7)
Pages: 1104-15
DOI
Peer Reviewed
-
-
-
-
-
-
-
-
-